Gapping down
In reaction to disappointing earnings/guidance:
In reaction to disappointing earnings/guidance:
- AIRG -6.9%, KMX -4.8%, GIS -1.1%
Other news:
- MSTX -81.3% ( reports top-line results from Phase 3 study in sickle cell disease; study did not meet its primary efficacy endpoint; will hold a conference call tomorrow)
- MIRN -23.6% (to close the ongoing Phase 1 study of MRX34, its investigational microRNA therapy for multiple cancers )
- CDNA -7.2% (announces a proposed offering of common stock)
- AERI -4.7% (cautious mention from biotech blogger Adam Feuerstein)
- PLM -2.4% ( to offer 13,333,333 Units at $0.75/Unit for gross proceeds of $10 mln in a private transaction)
- JKS -2.1% (still checking)
- NFLX -1.5% (presented at GS conf after mkt close yesterday)
- LEI -1.4% (ticking lower; files for 13,009,664 share common stock offering pursuant to the asset purchase agreement by selling stockholders)
Analyst comments:
- SKX -3.8% (downgraded to Equal-Weight from Overweight at Morgan Stanley)
- AAL -1.1% (downgraded to Mkt Perform from Outperform at Raymond James)
- POST -0.9% (downgraded to Mkt Perform from Outperform at BMO Capital )
- DO -0.7% (downgraded to Sell from Neutral at Goldman)